HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Iwata Selected Research

ACT regimen

8/2021Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Iwata Research Topics

Disease

58Neoplasms (Cancer)
11/2022 - 08/2003
30Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 08/2003
10Stomach Neoplasms (Stomach Cancer)
04/2016 - 03/2006
10Rectal Neoplasms (Rectal Cancer)
10/2015 - 03/2011
10Colorectal Neoplasms (Colorectal Cancer)
05/2014 - 11/2007
9Uterine Cervical Dysplasia
01/2022 - 12/2008
9Colonic Neoplasms (Colon Cancer)
01/2022 - 05/2005
9Adenocarcinoma
07/2021 - 10/2005
9Neoplasm Metastasis (Metastasis)
04/2015 - 11/2007
8Carcinogenesis
01/2020 - 08/2003
6Lung Neoplasms (Lung Cancer)
01/2022 - 12/2006
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2006
6Lymphatic Metastasis
12/2018 - 06/2012
5Carcinoma (Carcinomatosis)
01/2021 - 01/2009
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 08/2003
5Hemorrhage
12/2007 - 12/2005
4Squamous Intraepithelial Lesions
09/2019 - 02/2015
4Endometrial Neoplasms (Endometrial Cancer)
09/2015 - 08/2004
4Thymoma (Thymic Carcinoma)
06/2007 - 07/2006
3Melanoma (Melanoma, Malignant)
08/2021 - 05/2005
3Adenocarcinoma of Lung
12/2017 - 05/2011
3Microsatellite Instability
09/2015 - 08/2004
3Testicular Neoplasms (Testicular Cancer)
09/2012 - 05/2005
2Inguinal Hernia (Direct Inguinal Hernia)
01/2022 - 01/2012
2Fever (Fevers)
08/2021 - 01/2007
2Esophageal Neoplasms (Esophageal Cancer)
12/2018 - 09/2012
2Neuroendocrine Carcinoma
01/2018 - 02/2017
2Diarrhea
06/2015 - 01/2012
2Hypoxia (Hypoxemia)
09/2014 - 03/2013
2Inflammation (Inflammations)
09/2014 - 01/2007
2Hernia (Hernias)
08/2014 - 10/2010
2Aneurysm (Aneurysms)
11/2013 - 01/2012
2Infections
11/2013 - 08/2003
2Fistula
11/2013 - 04/2011
2Ileus
07/2012 - 01/2012
2Synovial Sarcoma (Synovioma)
02/2009 - 08/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2006 - 10/2005
1Hydronephrosis
08/2022

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2003
8AntigensIBA
02/2021 - 05/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2004
6Biomarkers (Surrogate Marker)IBA
10/2020 - 06/2012
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
5Immunoglobulin G (IgG)IBA
11/2018 - 05/2005
5CytokinesIBA
01/2017 - 01/2007
5Messenger RNA (mRNA)IBA
04/2015 - 01/2009
4Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 02/2011
4AntibodiesIBA
01/2020 - 10/2005
4Biological ProductsIBA
01/2019 - 08/2004
3Bevacizumab (Avastin)FDA Link
11/2022 - 06/2015
3Papillomavirus Vaccines (HPV Vaccines)IBA
04/2022 - 10/2014
3VaccinesIBA
01/2022 - 09/2019
3Transcription Factors (Transcription Factor)IBA
09/2021 - 02/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 04/2011
3Indicators and Reagents (Reagents)IBA
11/2020 - 06/2012
3Cyclin-Dependent Kinase Inhibitor p16IBA
02/2015 - 08/2003
3Sialyl Lewis X AntigenIBA
06/2012 - 01/2007
3Taxoids (Taxanes)IBA
08/2011 - 10/2007
2Carboplatin (JM8)FDA LinkGeneric
11/2022 - 01/2021
2Programmed Cell Death 1 ReceptorIBA
01/2022 - 04/2016
2CateninsIBA
01/2022 - 08/2021
2B7-H1 AntigenIBA
02/2021 - 01/2018
2Chimeric Antigen ReceptorsIBA
01/2020 - 01/2017
2NucleotidesIBA
01/2020 - 01/2018
2Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 10/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2015 - 09/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2015 - 08/2011
2Interleukin-13IBA
02/2015 - 05/2014
2Tumor Biomarkers (Tumor Markers)IBA
09/2014 - 06/2012
2protein kinase C lambdaIBA
08/2014 - 02/2014
2Cytidine DeaminaseIBA
08/2014 - 02/2014
2MicroRNAs (MicroRNA)IBA
01/2014 - 01/2013
2EnzymesIBA
03/2013 - 10/2005
2Complementary DNA (cDNA)IBA
09/2012 - 05/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2012 - 05/2011
2Antineoplastic Agents (Antineoplastics)IBA
01/2012 - 10/2007
2Methotrexate (Mexate)FDA LinkGeneric
01/2011 - 02/2009
2BilirubinIBA
10/2008 - 12/2007
2Keratin-19 (Keratin 19)IBA
12/2007 - 01/2007
1pembrolizumabIBA
11/2022
1Immunoconjugates (Immunoconjugate)IBA
08/2022

Therapy/Procedure

24Therapeutics
09/2022 - 12/2005
16Drug Therapy (Chemotherapy)
11/2022 - 02/2009
10Radiotherapy
11/2019 - 02/2009
9Chemoradiotherapy
11/2020 - 03/2011
8Lymph Node Excision (Lymph Node Dissection)
08/2022 - 03/2006
8Immunotherapy
01/2022 - 05/2005
7Hysterectomy
09/2022 - 01/2018
7Gastrectomy
04/2016 - 03/2006
6Trachelectomy
01/2021 - 10/2009
4Metastasectomy
02/2016 - 08/2007
4Colectomy
01/2015 - 08/2011
3Stents
08/2022 - 11/2013
3Laparotomy
08/2022 - 12/2007
3Neoadjuvant Therapy
04/2016 - 06/2006
3Sternotomy
01/2012 - 12/2006
3Thoracotomy
10/2010 - 10/2006
3Thymectomy
06/2007 - 07/2006
2Operative Surgical Procedures
05/2019 - 11/2007
2Kampo Medicine (Kampo)
01/2012 - 08/2011